Sophia Genetics Sa (SOPH)

Überblick Nachrichten Preisverlauf Optionskette Forum Prognose

Schlusskurs vom Vortag:

24-Stunden-Volumen:

Relative Volume:

Marktkapitalisierung:

Nettoeinkommen (Verlust:

Netto-Cashflow:

1W Leistung:

1M Leistung:

6M Leistung:

1J Leistung:

1-Tages-Spanne:

1-Wochen-Bereich:

52-Wochen-Spanne:

Sophia Genetics Sa Stock (SOPH) Company Profile

Sophia Genetics Sa

Healthcare (1233)

Nächster Verdiensttermin

Neueste SEC-Einreichungen

SOPH's Discussions on Twitter

Vergleichen Sie SOPH mit anderen Aktien

Aktien	Preis	Marktkapitalisierung	Umsatz	Nettogewinn	Free Cashflow	ENV
SOPH Sophia Genetics Sa	2.95	196.66M	62.37M	-78.98M	-57.80M	-1.22
VEEV Veeva Systems Inc	217.29	35.09B	2.66B	665.91M	1.08B	4.05
SOLV Solventum Corp	68.27	11.80B	8.26B	66.00M	1.17B	0.3682
DOCS Doximity Inc	52.53	9.75B	516.85M	174.11M	217.38M	0.87
HQY Healthequity Inc	100.09	8.68B	1.15B	96.70M	-161.99M	1.09
WAY Waystar Holding Corp	37.04	6.42B	906.14M	-52.62M	89.62M	-0.3621

Sophia Genetics Sa Stock (SOPH) Upgrades & Downgrades

Datum	Aktion	Analytiker	Ratingänderung
2024-12-18	Eingeleitet	Craig Hallum	Buy
2024-08-07	Herabstufung	Morgan Stanley	Overweight → Equal-Weight
2024-06-27	Eingeleitet	Guggenheim	Buy
2023-11-29	Eingeleitet	RBC Capital Mkts	Outperform
2023-07-05	Fortgesetzt	JP Morgan	Overweight
2023-01-03	Eingeleitet	BTIG Research	Buy
2022-11-23	Eingeleitet	Credit Suisse	Neutral
2021-10-15	Fortgesetzt	Cowen	Outperform
2021-08-17	Eingeleitet	Cowen	Outperform
2021-08-17	Eingeleitet	Credit Suisse	Outperform
2021-08-17	Eingeleitet	JP Morgan	Overweight
2021-08-17	Eingeleitet	Morgan Stanley	Overweight

Alle ansehen

Sophia Genetics Sa Aktie (SOPH) Neueste Nachrichten

Finanzdaten der Sophia Genetics Sa-Aktie (SOPH)

Sophia Genetics Sa (SOPH)

Sophia Genetics Sa Stock (SOPH) Company Profile

Vergleichen Sie SOPH mit anderen Aktien

Sophia Genetics Sa Stock (SOPH) Upgrades & Downgrades

Sophia Genetics Sa Aktie (SOPH) Neueste Nachrichten

Shareholders Should Be Pleased With SOPHiA GENETICS SA's (NASDAQ:SOPH) Price - Simply Wall St

Genomic Biomarkers Market Report: Personalized Medicine - GlobeNewswire

The Zacks Analyst Blog Highlights Tempus AI, iRhythm Technologies and SOPHiA GENETICS - Yahoo Finance

Tempus AI Stock Surges 23% In 6 Months: Should You Snap It Up Now? - Barchart

Radiomics Market Top Companies StudyRadiomics.io - openPR

Principal Financial Group Inc. Buys 86,764 Shares of SOPHiA GENETICS SA (NASDAQ:SOPH) - Defense World

JPMorgan Chase & Co. Purchases 1,399,131 Shares of iShares 5-10 Year Investment Grade Corporate Bond ETF (NASDAQ:IGIB) - Defense World

Short Interest in SOPHiA GENETICS SA (NASDAQ:SOPH) Grows By 38.6% - MarketBeat

SOPHiA GENETICS (NASDAQ:SOPH) Coverage Initiated at Craig Hallum - Defense World

Guggenheim Initiates Coverage of SOPHiA GENETICS (SOPH) with Buy Recommendation - MSN

Growth Trends in Europe's Precision Medicine Software - GlobeNewswire

SOPHiA GENETICS (NASDAQ:SOPH) Now Covered by Analysts at Craig Hallum - MarketBeat

Craig-Hallum Initiates Coverage of SOPHiA GENETICS (SOPH) with Buy Recommendation - MSN

SOPHiA GENETICS's SWOT analysis: biopharma firm navigates headwinds, eyes growth - Investing.com Australia

SOPHiA GENETICS's SWOT analysis: biopharma firm navigates headwinds, eyes growth By Investing.com - Investing.com South Africa

SOPHiA GENETICS SA (NASDAQ:SOPH) Short Interest Update - MarketBeat

Precision Medicine Software Market to Witness Substantial Growth and New Opportunities from 2024 to 2031 As... - WhaTech

US Penny Stocks To Watch In December 2024 - Simply Wall St

Bioinformatics Market to Grow by USD 13.2 Billion (2024-2028), Lower Genetic Sequencing Costs Drive Revenue, Report Highlights AI's Role in TransformationTechnavio - The Malaysian Reserve

SOPHiA GENETICS Reports Third Quarter 2024 Results - GuruFocus.com

Principal Financial Group Inc. Acquires 86,764 Shares of SOPHiA GENETICS SA (NASDAQ:SOPH) - Defense World

SOPHiA GENETICS Launches MSK-IMPACT® powered with SOPHiA DDM™ at AMP 2024 – Company Announcement - Financial Times

SOPHiA GENETICS Launches Advanced Cancer Profiling Platform with 99.3% Accuracy - StockTitan

SOPHiA GENETICS's SWOT analysis: data-driven medicine stock faces headwinds - Investing.com India

SOPHiA GENETICS (NASDAQ:SOPH) vs. SpringWorks Therapeutics (NASDAQ:SWTX) Financial Review - Defense World

Earnings Release: Here's Why Analysts Cut Their SOPHiA GENETICS SA (NASDAQ:SOPH) Price Target To US$6.00 - Yahoo Finance

SOPHiA GENETICS SA (NASDAQ:SOPH) Q3 2024 Earnings Call Transcript - Insider Monkey

Earnings call: SOPHiA GENETICS reported a16% year-over-year increase in analysis volume - Investing.com

SOPHiA GENETICS Third Quarter 2024 Earnings: Misses Expectations - Yahoo Finance

SOPHiA GENETICS Faces Financial Challenges Amid Losses - Yahoo Finance

Sophia Genetics SA (SOPH) Q3 2024 Earnings Call Highlights: Navigating Challenges with ... By GuruFocus - Investing.com Canada

SOPHiA GENETICS Q3 2024 Financial Highlights - TipRanks

SOPHiA GENETICS Promotes Ross Muken to President and Appoints George Cardoza as Chief Financial Officer - Marketscreener.com

3 Reasons Not to Give Up on Roku Stock - MSN

Vanguard Dethrones BlackRock As Second Largest ETF Manager: Here's How Their Funds With Exposure To S&P 500 Fared This Year - MSN

SOPHiA GENETICS Strengthens Leadership: Names New President, Appoints Industry Veteran CFO - StockTitan

Cofle S.p.A. Enhances Share Buyback Strategy - MSN

Adma Biologics (ADMA) Soars 18.8%: Is Further Upside Left in the Stock? - MSN

Palantir, Trump Media Buzz Amid Investors Ahead Of Election Day - MSN

SOS Limited announces ADS ratio change - MSN

Exploring Sophia Genetics's Earnings Expectations - Benzinga

Denmark stocks lower at close of trade; OMX Copenhagen 20 down 1.16% - MSN

IPO Roundup: Heritage Distilling, Transten Global and more - MSN

SOPHiA GENETICS SA (SOPH): A Bull Case Theory - Insider Monkey

Sophia Genetics SA (SOPH) Q3 2024: Everything You Need To Know Ahead Of Earnings - Yahoo Finance

Estimating at-risk couple rates across 1000 exome sequencing data cohort for 176 genes and its importance relevance for health policies - Nature.com

Fulgent Genetics (FLGT) Surges 5.8%: Is This an Indication of Further Gains? - Yahoo Finance

Morgan Stanley Downgrades Biogen (BIIB) - MSN

The biggest U.S. homebuilder misses on earnings as it says buyers are staying on the sidelines - MSN

Clime Capital Announces Quotation of New Shares - MSN

SOPHiA GENETICS (SOPH) to Release Quarterly Earnings on Tuesday - MarketBeat

Finanzdaten der Sophia Genetics Sa-Aktie (SOPH)

Umsatz

Nettogewinn

Free Cashflow

ENV

Ähnlich wie SOPH